Pharmaceutical Dialogues

    Pharmaceutical Dialogue
    Ausgabe 63 (September 2018)

    Parallel trade or parallel distribution is a business often attacked and more often misunderstood.

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 62 (Juli 2018)

    2019 marks the year when the Falsified Medicines Directive (FMD) will be fully implemented with sanctions being already in place for perpetrators.

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 61 (April 2018)

    With the beginning of 2018, the Bulgarian Presidency has taken over the Presidency to the Council of the EU for the first time.

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 60 (Dezember 2017)

    As the Institutions are getting ready for the Christmas break, the busy period is continuing and Bulgaria is preparing to take over the Presidency to the Council of the EU for the first time.

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 59 (Oktober 2017)

    As the summer break is over, the European Institutions are back to work. Numerous challenges in healthcare are still on the agenda also after the summer break.

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 58 (Juli 2017)

    The need fo Cyprus is following favourable policies to the parallel distribution of pharmaceuticals, aiming to support the consumers´ needs and the sustainability of its healthcare system [...]

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 57 (April 2017)

    The need for increased competition in the pharmaceutical sector has clearly emerged and manifested itself over recent courses. [...]

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 56 (Dezember 2016)

    We all face some busy weeks before the year comes to an end and Malta takes over the EU Presidency. [...]

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 55 (Oktober 2016)

    Parallel traders of pharmaceuticals are a responsible stakeholder within the supply chain. [...]

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 54 (Juli 2016)

    The availability of affordable pharmaceuticals is one of the challenges ahead to be ad-dressed by national and European decision makers. [...]

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 53 (April 2016)

    Forthcoming integration is crucial also on a number of additional fronts, including the EUwide response to the illegal trade of pharmaceuticals. Being a responsible stakeholder within the pharmaceutical supply chain, parallel traders contribute to its safety and authenticity. [...]

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 52 (Oktober 2015)

    With the beginning of 2016, the Netherlands will take over The Presidency of the Council of the European Union. The upcoming holder of the EU Presidency will target the affordability of medicines and the cost-efficiency potential of innovations within healthcare.

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 51 (Oktober 2015)

    By exploiting the virtue of the Internal Market, parallel trade of pharmaceuticals has contributed to the reduction of pharmaceutical costs by introducing products to the national markets at competitive prices. [...]

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 50 (Juli 2015)

    On July 1st, Luxembourg took over the presidency of the European Union. Despite the fact that the country offers one of the most comprehensive health care coverages in the EU, Luxembourg is also facing several challenges related to demographic changes. [...]

    jetzt lesen
    Pharmaceutical Dialogue
    Ausgabe 49 (April 2015)

    Given that the health care systems are subject to national regulations, the pharmaceutical market is also heterogeneous. Therefore, the EU has adopted a framework which aims at harmonizing the pharmaceutical sector in line with the subsidiarity principal.

    jetzt lesen